NEKTAR THERAPEUTICS·4

Oct 1, 8:24 PM ET

Lingnau Lutz 4

4 · NEKTAR THERAPEUTICS · Filed Oct 1, 2018

Insider Transaction Report

Form 4
Period: 2018-09-27
Lingnau Lutz
Director
Transactions
  • Award

    Stock Option

    2018-09-27+9,5009,500 total
    Exercise: $60.91Exp: 2026-09-26Common Stock (9,500 underlying)
  • Award

    Common Stock

    2018-09-27+4,75023,200 total
Footnotes (3)
  • [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
  • [F2]This restricted stock unit award vests in full, one year following September 27, 2018.
  • [F3]This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION